FDA NDC Directory · JSON-LD · Markdown

Oxcarbazepine

NDC 65162-649 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAmneal Pharmaceuticals LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA202961
Dosage form / routeSUSPENSION · ORAL
Active ingredientsOXCARBAZEPINE (300 mg/5mL)
Marketing started20120604
Package count2

External sources

Source: openFDA. Public-domain (CC0).